0001091818-20-000273.txt : 20201209
0001091818-20-000273.hdr.sgml : 20201209
20201209085453
ACCESSION NUMBER: 0001091818-20-000273
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201204
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAISER RICHARD KAISER
CENTRAL INDEX KEY: 0001663787
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51074
FILM NUMBER: 201377016
MAIL ADDRESS:
STREET 1: 3419 VIRGINIA BEACH BLVD, UNIT 252
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOFORCE NANOSCIENCES HOLDINGS, INC.
CENTRAL INDEX KEY: 0001310488
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 852138858
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 GENERAL BOOTH BLVD
STREET 2: SUITE 230
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23454
BUSINESS PHONE: 757-306-6090
MAIL ADDRESS:
STREET 1: 2020 GENERAL BOOTH BLVD
STREET 2: SUITE 230
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23454
FORMER COMPANY:
FORMER CONFORMED NAME: SILVER RIVER VENTURES, INC.
DATE OF NAME CHANGE: 20041202
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2020-12-04
2020-12-07
0
0001310488
BIOFORCE NANOSCIENCES HOLDINGS, INC.
BFNH
0001663787
KAISER RICHARD KAISER
3419 VIRGINIA BEACH BLVD, UNIT 252
VIRGINIA BEACH
VA
23452
1
1
1
0
CFO
Common Stock
2020-12-04
4
A
0
3000000
0.001
A
5050000
D
Convetible Preferred 'A'
0.001
2020-12-04
4
M
0
500000
0.001
D
2020-03-31
2040-03-31
Common Stock
3000000
0
D
On December 4, 2020, BioForce Nanosciences Holdings, Inc. (The "Company" or the "Registrant") issued 3,000,000 shares of its common stock to the reporting individual in exchange for 500,000 shares of its Preferred Series 'A' shares. These shares were issued pursuant to an exemption from registration provided by Section 4(2) of the Securities Act of 1933. The issuance was not a public offering as defined in Section4(2)due to the limited number of persons that received the shares, and the matter of the issuances. In addition, the transferee of the common stock represented that they had the necessary investment intent as required by Section 4(2) and agreed to receive shares containing a legend that states the securities were restricted pursuant to Rule 144 of the Securities Act.
This Amendment No. 3 on FORM 4/A is to correct the wrongly input of the "Date Exercisable and Expiration Date" on Column #6 on TABLE II. The Date was correctly input on the original filing, FORM 4 on Dec.07, 2020, but the two prior amendments on FORM 4/A had these dates wrong as being Date Exercisable - 12/31/2020 and Expiration Date -12/31/2040. The Correct dates are now input correctly on this Amendment No. 3 on FORM 4/A as being Date Exercisable- 03/31/2020 and Expiration Date - 03/31/2040.
/s/ Richard Kaiser
2020-12-09